Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53,364,241
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
17,536,133
-
Shares change
-
+5,047,553
-
Total reported value, excl. options
-
$129,064,483
-
Value change
-
+$37,153,425
-
Number of buys
-
42
-
Number of sells
-
-11
-
Price
-
$7.36
Significant Holders of scPharmaceuticals Inc. - Common Stock (SCPH) as of Q2 2020
56 filings reported holding SCPH - scPharmaceuticals Inc. - Common Stock as of Q2 2020.
scPharmaceuticals Inc. - Common Stock (SCPH) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17,536,133 shares
of 53,364,241 outstanding shares and own 32.86% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (4,797,148 shares), 5AM Venture Management, LLC (3,831,474 shares), RA CAPITAL MANAGEMENT, L.P. (3,518,998 shares), Ikarian Capital, LLC (1,468,647 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (747,989 shares), VANGUARD GROUP INC (587,599 shares), Alyeska Investment Group, L.P. (388,603 shares), RENAISSANCE TECHNOLOGIES LLC (333,686 shares), BlackRock Inc. (258,360 shares), and Eversept Partners, LP (247,419 shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.